|
GVK Biosciences
|
|
GVK Biosciences (commonly referred to as GVK BIO) is a Contract Research Organization offering services in Integrated Drug Discovery, Chemistry, Biology, Large Molecule R&D, Chemical Development, Formulation, Analytical Development, Contract Manufacturing and Drug Repurposing. The Head Office is located in Hyderabad, India. History GVK BIO was started in 2001 as a part of GVK Group. Mr. D S Brar, the former CEO of Ranbaxy Laboratories joined GVK Biosciences as its promoter Chairman in the year 2004. Manni Kantipudi, is the CEO of the company. Company & Infrastructure The company has an infrastructure spread across 55 acres, with a built-up area of more than 1,200,000 square feet, housing chemistry & biology labs, AAALAC accredited animal house, GMP compliant analytical labs, formulation development labs, kilo labs, pilot plants and manufacturing facilities. Offices The company is headquartered in Hyderabad with global offices in the USA and Netherlands and research centers in San Francisco, Hyderabad and Bangalore. The manufacturing facilities are located in Hyderabad and a facility in Vizag has been announced. Timeline *2001: GVK Biosciences commenced operations on April 2, 2001 with the Informatics division *2005: GVK Biosciences acquires Daiichi Karkaria to set Inogent Labs *2006: GVK Biosciences to provide research services for Wyeth Pharma * 2007: Sequoia Capital, private equity firm invests in GVK BIO * 2008: Entered into first collaborative research deal with Dow AgroSciences * 2011: Dow AgroSciences, GVK Biosciences Identify New Lead Molecule * 2015: ChrysCapital enters GVK BIO 
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
